跳至主要内容
临床试验/NCT07462312
NCT07462312招募中不适用

Evaluating the Efficacy of the MentalGym™ and NeuroBrave™ Guided Wearable-Assisted Physiology Regulation Training for PTSD: A Randomized Controlled Trial

NeuroBrave ltd.1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年9月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
Change in PTSD Symptom Severity (PCL-5 Total Score)

研究概览

简要总结

This randomized controlled trial (RCT) will evaluate the effectiveness of a digital biofeedback-based intervention ("Mental Gym®") designed to reduce Posttraumatic Stress Disorder (PTSD) symptoms and improve mental health. The intervention combines daily HRV biofeedback exercises using a wearable device (Garmin watch), a dedicated mobile application, and weekly group guidance sessions. A delayed-intervention control group design will be used. To account for expected attrition and ensure a final sample of 60 participants, approximately 80 subjects will be recruited. Physiological and self-report data will be collected pre- and post-intervention, weekly during the intervention, and at follow-ups (3 months post-intervention). The study population consists of combat veterans diagnosed with PTSD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

This is an open-label behavioural/digital intervention. Due to the nature of the intervention, participants and study staff are not blinded to group assignment.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18 Years and older.
  • Diagnosis: Clinical diagnosis of Posttraumatic Stress Disorder (PTSD) with mild to moderate-severe symptom intensity.
  • Symptom Severity: A PCL-5 total score of up to 60 at screening.
  • Traumatic Event: PTSD diagnosis based on a traumatic event that occurred in the year 2000 or later.
  • Service Eligibility: Eligibility for Ministry of Defense (MOD) rehabilitation services.
  • Technical Proficiency: Ability to use a smartphone and a wearable device.

排除标准

  • High Symptom Severity: PTSD symptom severity exceeding the moderate-severe range (PCL-5 score > 60) or requiring more intensive clinical intervention.
  • Psychiatric Stability: Acute psychiatric instability, including active suicidal ideation or psychosis.
  • Medication: Current use of Olanzapine (Zyprexa) or Quetiapine (Seroquel).
  • Sleep Disturbances: Severe sleep impairment (score > 7 on the The Insomnia Severity Index).
  • Functional Impairment: Severe impairment in concentration or cognitive processing that precludes the use of digital biofeedback tools.

研究组 & 干预措施

Delayed Intervention (Waitlist Control plus Garmin Watch)

No Intervention

Participants in this arm will initially serve as a no-intervention control group for a period of 8 weeks, during which they will continue with their Treatment as Usual (TAU). Following this 8-week period, they will receive the full 'Mental Gym®' intervention, identical to the experimental group, including the mobile application, and weekly sessions.

Mental Gym® Immediate Intervention

Active Comparator

干预措施: Mental Gym® Biofeedback System (Behavioral)

结局指标

主要结局

Change in PTSD Symptom Severity (PCL-5 Total Score)

时间窗: Baseline (Week 0) and Post-Intervention (Week 8).

The primary outcome is the change in the total score of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). The PCL-5 is a 20-item self-report measure; items are rated on a 0-4 point scale. Total score ranges from 0 to 80, where higher scores indicate greater symptom severity. PCL scores are expected to reduce in the intervention but not in the control groups.

次要结局

  • Long term retention of Treatment Effects in the Intervention Group(Baseline (Week 0), Post-Intervention (Week 8), 1.5-month Follow-up (Week 14), and 3-month Follow-up (Week 20))
  • Change in Autonomic Regulation (Resting HRV)(Baseline (Week 0) and Post-Intervention (Week 8))
  • Change in Generalized Anxiety Symptoms (GAD-7)(Baseline (Week 0) and Post-Intervention (Week 8))
  • Change in Depressive Symptoms (PHQ-9)(Baseline (Week 0), Post-Intervention (Week 8))
  • Change in Psychological Resilience (CD-RISC-10)(Baseline (Week 0), Post-Intervention (Week 8))
  • Change in Sleep Quality (ISI)(Baseline (Week 0), Post-Intervention (Week 8))

研究者

发起方
NeuroBrave ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验